| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Manish Dhanuka CEO | XNSE Exchange | INE191A01027 ISIN |
| India Country | 736 Employees | 13 Sep 2012 Last Dividend | 25 Jul 2019 Last Split | - IPO Date |
Orchid Pharma Limited is a prominent entity in the pharmaceutical industry, based in Chennai, India. Since its inception in 1992, the company has been at the forefront of developing, manufacturing, and marketing a wide range of pharmaceutical products, including active pharmaceutical ingredients (APIs), bulk actives, finished dosage formulations, and nutraceuticals. Originally operating under the name Orchid Chemicals & Pharmaceuticals Limited, it rebranded to Orchid Pharma Limited in October 2015. Orchid Pharma has carved a niche for itself not only in India but also on an international scale, exporting products to around 40 countries. A significant milestone in its journey was becoming a subsidiary of Dhanuka Laboratories Limited, which has further strengthened its position in the market. The company's dedication to quality and innovation has earned it a reputable stance in the pharmaceutical domain, offering a variety of products across multiple therapeutics areas.
This category encompasses a diverse range of critical ingredients used in the formulation of drugs. Orchid Pharma's portfolio includes oral and injectable cephalosporins, veterinary products, and non-antibiotics. These APIs are pivotal for the company’s multi-therapeutic offerings, catering to anti-infectives, anti-inflammatory, and cardiovascular segments among others.
In addition to APIs, Orchid Pharma specializes in the development and manufacture of finished dosage formulations. These are ready-to-use pharmaceutical products made from active ingredients, designed for consumer use in various therapeutic areas. The company's formulations are distributed domestically and internationally, highlighting its capability to meet global pharmaceutical standards.
Recognizing the importance of nutrition in healthcare, Orchid Pharma offers a range of nutraceutical products. These products include dietary supplements and functional foods that provide health benefits beyond basic nutrition, supporting overall well-being and addressing specific health conditions.
Orchid Pharma is not just a manufacturing entity; it also contributes to the pharmaceutical industry through its research and development services. The company invests in new drug discovery systems aiming at the continuous improvement and innovation of drugs. This not only demonstrates Orchid Pharma’s commitment to advancing healthcare solutions but also positions it as a key player in pharmaceutical R&D.